Biochem/physiol Actions

Primary TargetnAch

General description

A potent competitive antagonist of nAChR (IC50= 41 nM). Used as nondepolarizing muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvant.

A potent competitive antagonist of nAChR (IC₅₀ = 41 nM). Used as nondepolarizing muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvant.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.

Bowman, C., 2006. Br. J. Pharmacol.147, S277.Wenningmann, I., et al. 2001. Mol. Pharmacol.60, 790.Pederson, X., 1990. Proc. Natl. Acad. Sci. USA.87, 2785.

Packaging

10 mg in Glass bottle

Preparation Note

Warming is required for complete solubilization.

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.

Warning

Toxicity: Toxic (F)